Kiyean Nam

Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis

Kévin Pethe, Pablo Bifani, Jichan Jang et al. · Nature Medicine · 2013 · 595 citations · Full text

Medicinal Chemistry, Potent Clinical Candidate, Pulmonary Tuberculosis +7

Lead Optimization of a Novel Series of Imidazo[1,2-<i>a</i>]pyridine Amides Leading to a Clinical Candidate (Q203) as a Multi- and Extensively-Drug-Resistant Anti-tuberculosis Agent

Sun‐Hee Kang, Ryang Yeo Kim, Min Jung Seo et al. · Journal of Medicinal Chemistry · 2014 · 173 citations · Full text

Pharmaceutical Science, Bioorganic Chemistry, Extensively-drug-resistant Anti-tuberculosis Agent +18

Glucocorticoid Receptor Antagonism by Cyproterone Acetate and RU486

Christian Honer, Kiyean Nam, Cynthia A. Fink et al. · Molecular Pharmacology · 2003 · 90 citations

Synthesis and structure-activity studies of side chain analogues of the anti-tubercular agent, Q203

Sun‐Hee Kang, Young Mi Kim, Ryang Yeo Kim et al. · European Journal of Medicinal Chemistry · 2016 · 40 citations

Biochemistry, Medicine, Structure-activity Studies +6

Safety, Tolerability, and Pharmacokinetics of Telacebec (Q203), a New Antituberculosis Agent, in Healthy Subjects

Jeongjun Kim, Jin‐Ho Choi, Hwankyu Kang et al. · Antimicrobial Agents and Chemotherapy · 2021 · 37 citations · Full text